Wolfgang Miesbach: Therapeutic Potential of Protein S Inhibition in Glanzmann Thrombasthenia
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article by Rim Diab et al, published in ASH, adding:
“Honored to have attended last weekend’s EHA‑SWG Scientific Meeting on Bleeding and Platelet Disorders, where Rim Diab from the Anne Angelillo-Scherrer group presented her inspiring work on ‘Enhancing Hemostasis in Glanzmann Thrombasthenia via Protein S Inhibition.’
I particularly appreciated how she concluded by reminding us that Glanzmann himself was a Swiss pediatrician who first described this rare platelet disorder in 1918 during his tenure at the Children’s Hospital in Bern, Switzerland — beautifully linking the roots of the disease to today’s one of the most exciting haemostasis research.”
Title: Enhancing hemostasis in glanzmann thrombasthenia via protein S inhibition
Authors: Rim Diab, Tanja Knopp, Mathieu Fiore, Sonia Avoue-celerier, Léonard Julien Simon Schacher, Raja Prince-Eladnani, Anne Angelillo-Scherrer
Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Jun 8, 2026, 06:30Caryn Blumenfeld: Team Zakophilia and Ratner’s Runners Even Though It’s A Walk!
-
Jun 8, 2026, 06:25Cécile Jefford: The NEHA Community and the Power of Human Connection
-
Jun 8, 2026, 06:02Manoj K: How Incyte Could Help Transform Care for Patients With von Willebrand Disease
-
Jun 8, 2026, 03:05Shamsunisha Yusuff: Iron Down, Platelets Up in a Young CBC ?
-
Jun 8, 2026, 03:03Samwel Mikaye: D-Dimer – A Marker of Blood Clot Breakdown
-
Jun 8, 2026, 02:59Vinita Madhuri: Our Engagement, A Lifeline for Thalassemia Patients
-
Jun 7, 2026, 22:11Lucia Härtel: Exercise, IL-10 Signaling, and Post-Stroke Brain Plasticity
-
Jun 7, 2026, 19:35Ashish Pemawat: Is the 4.5-Hour Thrombolysis Window Becoming Less Relevant?
-
Jun 7, 2026, 18:25Nita Radhakrishnan: Every Child Cured Is a Reminder of What Can Be Achieved When We Work Together